Your browser doesn't support javascript.
How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes?
Fotouhi, Maryam; Samami, Elham; Mohseni, Sahar; Nasrollahizadeh, Amir; Haddadi, Mohammad; Mirbeyk, Mona; Saghazadeh, Amene; Rezaei, Nima.
  • Fotouhi M; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Samami E; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohseni S; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Nasrollahizadeh A; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Haddadi M; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Mirbeyk M; School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
  • Saghazadeh A; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Rezaei N; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Adv Exp Med Biol ; 1318: 293-313, 2021.
Article in English | MEDLINE | ID: covidwho-1222720
ABSTRACT
Novel coronavirus disease 2019 (COVID-19) has posed a crucial hazard to global health. The new species share similarities with the two previously emerged entities severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) that have caused outbreaks in 2002 and 2012, respectively. Interestingly, all of these coronaviruses can cause potentially fatal respiratory syndromes, though behave differently in patients with cancer compared to patients without cancer. Accordingly, the present chapter aims to, through a systematic investigation, estimate the prevalence of cancer among COVID-19, SARS, and MERS confirmed cases. Our analysis based on data from 78 studies with SARS, MERS, and COVID-19 confirmed cases showed that the prevalence of cancer (4.94%) stands at fourth place after hypertension (20.8%), diabetes (11.39%), and cardiovascular diseases (7.46%). According to the findings of the present study, comorbidities are significantly more common in patients with MERS compared to patients with COVID-19 and SARS, and this was the cancer case as well. Further studies need to address whether or not patients with coronaviruses and cancer are different from patients with coronaviruses without cancer in terms of clinical manifestations, laboratory findings, outcomes, and men to women ratio.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / Middle East Respiratory Syndrome Coronavirus / COVID-19 / Neoplasms Type of study: Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Female / Humans / Male Language: English Journal: Adv Exp Med Biol Year: 2021 Document Type: Article Affiliation country: 978-3-030-63761-3_17

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / Middle East Respiratory Syndrome Coronavirus / COVID-19 / Neoplasms Type of study: Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Female / Humans / Male Language: English Journal: Adv Exp Med Biol Year: 2021 Document Type: Article Affiliation country: 978-3-030-63761-3_17